Bristol Myers Squibb Lawrenceville Gas Power Plant, New Jersey, USA

Bristol Myers Squibb Lawrenceville is a gas-fired power generation facility located in Lawrenceville, New Jersey, United States. With a capacity of 5.5 MW, it is a small-scale plant primarily serving the energy demands of the Bristol-Myers Squibb pharmaceutical site. The plant is operational and owned by Bristol-Myers Squibb Co. The facility operates on natural gas, a cleaner-burning fossil fuel compared to coal, resulting in lower emissions of sulfur dioxide (SO2) and particulate matter. As a small combined heat and power (CHP) or simple-cycle unit, it likely provides both electricity and thermal energy for the manufacturing processes. The plant falls under the regulatory purview of the U.S. Environmental Protection Agency (EPA) and must comply with the Clean Air Act (CAA) standards, including New Source Performance Standards (NSPS) for stationary gas turbines. This on-site generation enhances energy reliability for the pharmaceutical operations and reduces transmission losses. The plant's small capacity and use of natural gas contribute to a lower environmental footprint compared to larger fossil fuel plants. Its location in a suburban area near Princeton underscores the importance of local power generation for industrial facilities.

The plant's use of natural gas results in lower CO2 emissions per MWh compared to coal or oil, but still contributes to greenhouse gas emissions. Its small capacity (5.5 MW) limits local air quality impacts, though proximity to residential areas may require adherence to state-level air permitting. The facility likely operates under a Title V operating permit or a synthetic minor permit, ensuring compliance with National Ambient Air Quality Standards (NAAQS).